Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - KeraVision, Inc. (OTC BB:KERA.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Chart | News | Profile
Recent Events
Aug 20Price hit new 52-week low ($0.01)
Location
48630 Milmont Drive
Fremont, CA 94538
Phone: (510) 353-3000
Fax: (510) 353-3030
Employees (last reported count): 172
Financial Links
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Related Links
 ·Search Yahoo! for related links...
Ownership
·Insider and 5%+ Owners: 16%
·Institutional: 7% (9% of float)
(21 institutions)
·Net Inst. Buying: 706.0K shares (+33.48%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
KeraVision, Inc. developed a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia (nearsightedness), hyperopia (farsightedness) and astigmatism, to offer an alternative to eyeglasses, contact lenses and other vision correction surgical procedures. Its first product, Intacs corneal ring segments, based on the Company's proprietary patented technology, has been approved by the Food and Drug Administration for correcting mild myopia. Intacs are designed to permanently correct a patient's vision while providing the option of removability. The placement of Intacs is a simple, minimally invasive procedure that can be performed on an outpatient basis typically in 15 minutes or less. In March 2001, the Company filed for protection pursuant to Chapter 11 of the United States Bankruptcy Code.
More from Market Guide: Expanded Business Description

Financial Summary
KeraVision, Inc. was founded to develop and commercialize proprietary medical products for the treatment of common vision problems, including myopia, hyperopia and astigmatism. For the fiscal year ended 12/31/00, net sales fell 77% to $2.4 million. Net loss applicable to Common rose 38% to $39.8 million. Results reflect lower sales of training-related surgeon kits due to the reduction in new surgeon training, partially offset by lower research and development expenses.
More from Market Guide: Significant Developments

Officers
FY1999 Pay

Steven Henderson, 40
VP of Sales
--  
David Heniges, 56
VP - Europe
$193K
Richard Meader, 54
VP - Quality Assurance
--  
Michael Taylor, 49
VP, Corp. Relations
--  
Robert Wood, 41
VP, Manufacturing
--  
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:KERA.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 20-Aug-2001
$0.01 
Recent Price$0.02 
52-Week High
on 29-Sep-2000
$4.125
Beta2.11 
Daily Volume (3-month avg)51.1K
Daily Volume (10-day avg)16.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-99.5%
52-Week Change
relative to S&P500
-99.3%
Share-Related Items
Market Capitalization$378.0K
Shares Outstanding18.9M
Float15.9M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.60 
Earnings (ttm)-$2.12 
Earnings (mrq)-$0.52 
Sales (ttm)$0.13 
Cash (mrq)$0.71 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)0.15 
Income Statements
Sales (ttm)$2.45M
EBITDA (ttm)-$38.3M
Income available to common (ttm)-$39.8M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter31-Dec-2000
Management Effectiveness
Return on Assets (ttm)-101.13%
Return on Equity (ttm)-481.52%
Financial Strength
Current Ratio (mrq)1.58 
Debt/Equity (mrq)0.08 
Total Cash (mrq)$13.1M
Short Interest
As of 8-Feb-2001
Shares Short3.22M
Percent of Float20.3%
Shares Short
(Prior Month)
3.56M
Short Ratio21.77 
Daily Volume148.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-Dec-2000)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.